Intrinsiqs

Is AnaptysBio, Inc. overvalued?

AnaptysBio, Inc. (ANAB) — key valuation metrics and fundamentals.

No verdict
Price
$67.77
Fair value
Current P/E
Normal P/E
Market cap
$2.88B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares ANAB's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.